Skip to main content

Can Ficicioglu, MD, PhD

Can Ficicioglu, MD, PhD

Can Ficicioglu, MD, PhD

Can Ficicioglu, MD, PhD, is Director of the Newborn Metabolic Screening Program and the Lysosomal Storage Diseases Program, and Clinical Director of the Metabolic Disease Program at Children's Hospital of Philadelphia.

Areas of expertise: Fatty acid oxidation defects, Galactosemia, Lysosomal Storage Disorders, Newborn metabolic screening, Phenylketonuria (PKU), Metabolic genetic disorders, Pediatric clinical genetics

Locations: Main Building


215-590-3376

About Can Ficicioglu, MD, PhD

Titles

Director, Newborn Metabolic Screening Program

Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

Certifications

Clinical Biochemical Genetics – American Board of Medical Genetics and Genomics

Pediatrics – American Board of Pediatrics

Awards and Honors

2022, Philadelphia Magazine's Top Doctors in Clinical Genetics

Education & training

Medical Degree

University of Istanbul, Cerrahpasa Medical School, Istanbul, Turkey

Internship

University of Istanbul, Cerrahpasa Medical School

Residency

Albert Einstein Medical College, Montefiore Hospital and Medical Center, New York Medical College and St. Vincent's Catholic Medical Center, New York, N.Y.

Fellowship

Harvard Medical School and Children's Hospital Boston, Boston, Mass.

Publications

Publications

 

Ficicioglu C, Hussa C, Gallagher PR, Thomas N, Yager C. Monitoring of biochemical status in children with Duarte galactosemia: utility of galactose, galactitol, galactonate, and galactose 1-phosphate. Clin Chem. 2010 Jul;56(7):1177-82. Epub 2010 May 20.

Freer DE, Ficicioglu C, Finegold D. Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach. Clin Chem. 2010 Mar;56(3):437-44. Epub 2010 Jan 14.

Ficicioglu C, An Haack K. Failure to thrive: when to suspect inborn errors of metabolism. Pediatrics. 2009 Sep;124(3):972-9. Epub 2009 Aug 10.

Arnold GL, Van Hove J, Freedenberg D, Strauss A, Longo N, Burton B, Garganta C, Ficicioglu C, Cederbaum S, Harding C, Boles RG, Matern D, Chakraborty P, Feigenbaum A. A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2009 Mar;96(3):85-90. Epub 2009 Jan 20.

Ficicioglu C, Coughlin CR 2nd, Bennett MJ, Yudkoff M. Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr. 2010 Mar;156(3):492-4. Epub 2010 Jan 8.

Coughlin CR 2nd, Ficicioglu C. Genotype-phenotype correlations: sudden death in an infant with very-long-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis. 2010 Jan 27. [Epub ahead of print]

Patient experience rating

(based on 43 submissions)

  • Clear Explanation
    4.9 of 5
  • Showed Concern
    4.9 of 5
  • Included in decisions
    4.9 of 5
  • Would recommend
    5 of 5
  • Discussion of Proposed Treatment
    4.9 of 5
Learn about the patient experience rating system

About the Patient Experience Rating System

The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question. Responses are measured on a scale of 1 to 5 with 5 being the best score. We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient’s protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments. Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care. The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.

Jump back to top